Compared to Estimates, Xerox (XRX) Q2 Earnings: A Look at Key Metrics

Xerox Holdings Corporation (XRX) reported a challenging Q2, with revenue of $1.58 billion, a 0.1% year-over-year decrease, and a significant EPS loss of -$0.64, sharply down from $0.29 in the prior year. These results substantially missed analyst consensus estimates, with revenue surprising by -0.75% and EPS by a notable -740%. The company's stock has underperformed the S&P 500 over the past month, reflecting investor concerns over its financial health.

Analysis

Xerox Holdings Corporation (XRX) delivered a significantly weak performance in its Q2 2025 earnings report, underscored by a profound miss on profitability. The company reported an EPS of -$0.64, a stark reversal from the $0.29 profit in the prior-year quarter and a -740% negative surprise against the consensus estimate of $0.10. While top-line revenue of $1.58 billion was nearly flat year-over-year with a -0.1% decline, it still missed analyst expectations by -0.75%. A deeper look into the revenue components reveals critical weaknesses, particularly in high-value segments. High-end equipment sales plummeted by -26.7% year-over-year, and post-sale revenue from supplies and paper fell dramatically short of estimates, reporting $176 million versus an expected $268.33 million. This suggests eroding demand for both new premium products and consumables for the existing installed base. Although the broader 'Revenues - Sales' category showed an 8.8% YoY increase, this was insufficient to offset the secular declines in core areas. The market has reacted accordingly, with XRX shares returning -9.2% over the past month, severely underperforming the S&P 500 composite's +2.7% gain.

Key Decisions for Investors

• The substantial EPS miss, shifting from profit to a significant loss, warrants a cautious stance as it indicates severe pressure on profitability and operational efficiency.
• Investors should scrutinize the steep 26.7% year-over-year decline in high-end equipment sales and the large miss in recurring post-sale supplies revenue, as these signal deteriorating fundamentals in historically key business areas.
• Given the stock's recent underperformance and the deeply negative earnings surprise, investors may consider reducing exposure or hedging positions, as the neutral Zacks Rank #3 (Hold) may not fully capture the near-term downside risk highlighted by these results.